UK Cell Penetrating Peptide Market Size & Outlook

The cell penetrating peptide market in UK is expected to reach a projected revenue of US$ 126.5 million by 2030. A compound annual growth rate of 10.8% is expected of UK cell penetrating peptide market from 2024 to 2030.
Revenue, 2023 (US$M)
$61.8
Forecast, 2030 (US$M)
$126.5
CAGR, 2024 - 2030
10.8%
Report Coverage
UK

UK cell penetrating peptide market, 2018-2030 (US$M)

UK

UK cell penetrating peptide market highlights

  • The UK cell penetrating peptide market generated a revenue of USD 61.8 million in 2023 and is expected to reach USD 126.5 million by 2030.
  • The UK market is expected to grow at a CAGR of 10.8% from 2024 to 2030.
  • In terms of segment, synthetic cpps was the largest revenue generating type in 2023.
  • Protein-Derived CPPs is the most lucrative type segment registering the fastest growth during the forecast period.


Cell penetrating peptide market data book summary

Market revenue in 2023USD 61.8 million
Market revenue in 2030USD 126.5 million
Growth rate10.8% (CAGR from 2023 to 2030)
Largest segmentSynthetic cpps
Fastest growing segmentProtein-Derived CPPs
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationProtein-Derived CPPs, Synthetic CPPs, Chimeric CPPs
Key market players worldwideBiosynth, Creative Peptides, Cupid Peptides, Alta Bioscience Ltd, AnaSpec, Peptomyc, Sarepta Therapeutics Inc, Revance Therapeutics Inc, PolyPeptide Group AG, Bachem Holding AG


Other key industry trends

  • In terms of revenue, UK accounted for 4.2% of the global cell penetrating peptide market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany cell penetrating peptide market is projected to lead the regional market in terms of revenue in 2030.
  • Denmark is the fastest growing regional market in Europe and is projected to reach USD 7.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell Penetrating Peptide Market Companies

Name Profile # Employees HQ Website

UK cell penetrating peptide market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell penetrating peptide market will help companies and investors design strategic landscapes.


Synthetic cpps was the largest segment with a revenue share of 54.85% in 2023. Horizon Databook has segmented the UK cell penetrating peptide market based on protein-derived cpps, synthetic cpps, chimeric cpps covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to UK cell penetrating peptide market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK cell penetrating peptide market databook

  • Our clientele includes a mix of cell penetrating peptide market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK cell penetrating peptide market, including forecasts for subscribers. This country databook contains high-level insights into UK cell penetrating peptide market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UK cell penetrating peptide market report size, by type, 2018-2030 (US$M)

UK Cell Penetrating Peptide Market Share, 2023 & 2030 (US$M)

UK cell penetrating peptide market report size, by type, 2018-2030 (US$M)

Related industry reports

No records

No related industry reports found.

Related regional statistics

No records

No related regions found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more